Organization · Incubator
i&i Prague
i&i Prague is a biotech incubator and venture builder that supports the commercialization of innovative life sciences projects from early-stage development to market entry, primarily focusing on biotech innovations from academic institutions in Central Europe.
Overview
What i&i Prague does
What i&i Prague is
i&i Prague is a biotech incubator and venture builder that supports the commercialization of innovative life sciences projects from early-stage development to market entry, primarily focusing on biotech innovations from academic institutions in Central Europe.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Incubator
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder · Program host
- Last reviewed
- April 13, 2026
What Incubator means
An incubator is a support environment for turning a nascent idea or early company into a startup that is more ready for customers, funding, or an accelerator.
Open the glossary entryOfficial channels
Find i&i Prague elsewhere
Open the official website or a supported primary organization account.
Capability profile
i&i Prague as a funder
Investment thesis
i&i Prague supports early-stage biotech startups by providing expert consulting and structured incubation programs to commercialize scientific innovations.
Focus narrative
i&i Prague invests in early-stage biotech projects, particularly in drug discovery, medical devices, diagnostics, and digital health. The organization provides a structured incubation program that includes market analysis, initial funding, and industry feedback, with a focus on commercializing scientific innovations primarily from the Czech Republic and Poland.
Value beyond capital
i&i Prague adds value to its portfolio companies by providing expert consulting, structured incubation programs, and ongoing support tailored to the specific needs of each startup, facilitating their growth and commercialization efforts.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 11
Portfolio context
Notable portfolio companies include: Adalid Science: Develops novel lipid nanoparticles for effective drug delivery. Dracen Pharmaceuticals: Focuses on tumor-directed glutamine antagonists. PerioTrap: Works on curative treatments for periodontitis. Sophomer: Specializes in synthetic polymers for immunoassays. CasInvent Pharma: Develops casein kinase 1 inhibitors for cancer treatment. LAM-X: Creates light-activated nanomaterials to combat infections. Reecyclium: Engages in the separation of rare elements from permanent magnets. Sulfotools: Innovates in green peptide synthesis technology. Deep MedChem: Utilizes AI-based tools to accelerate drug discovery. Pep-Therapy: Focuses on innovative peptides for oncology. Sampling Human: Develops yeast cell-based biocomputing solutions.
Capability profile
i&i Prague as a program host
Program thesis
i&i Prague is a biotech incubator and venture builder focused on supporting early-stage startups in drug development, diagnostics, and medical technologies.
Focus narrative
i&i Prague invests in early-stage biotech projects, particularly in drug discovery, medical devices, diagnostics, and digital health. The organization offers a structured incubation program that includes market analysis, initial funding, and industry feedback, aiming to commercialize scientific innovations primarily from the Czech Republic and Poland.
Value and support
i&i Prague provides expert consulting, structured incubation programs, market analysis, initial funding, and ongoing support tailored to the needs of startups.
Format and cadence
- Typical duration
- 156 weeks
Availability
- Application state
- Not published
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- Europe · Pl
Alumni and track record
Alumni context
Notable portfolio companies include Adalid Science, which develops novel lipid nanoparticles for effective drug delivery; Dracen Pharmaceuticals, focusing on tumor-directed glutamine antagonists; PerioTrap, working on curative treatments for periodontitis; Sophomer, specializing in synthetic polymers for immunoassays; and CasInvent Pharma, which develops casein kinase 1 inhibitors for cancer treatment.
Common questions
What to know about i&i Prague
Upseed classifies i&i Prague under the Incubator organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 13, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.